View of Pharmacogenomic Profiling of DPYD Mutations and Genotype‑guided Dose Adjustment to Prevent Fluoropyrimidine Toxicity in Gastrointestinal Cancer Patients: A Real‑world Study from North India

Return to Article Details Pharmacogenomic Profiling of DPYD Mutations and Genotype‑guided Dose Adjustment to Prevent Fluoropyrimidine Toxicity in Gastrointestinal Cancer Patients: A Real‑world Study from North India Download Download PDF